Derya Onel

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study.

Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study.

Journal: Postgraduate medicine

Published: April 08, 2016

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection.

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection.

Journal: European review for medical and pharmacological sciences

Published: March 25, 2016

Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.

Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 07, 2016

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 14, 2014

Acute hepatitis B due to immune-escape mutations in a naturally immune patient.

Acute hepatitis B due to immune-escape mutations in a naturally immune patient.

Journal: Acta gastro-enterologica Belgica

Published: August 06, 2014

Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B.

Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B.

Journal: Antiviral therapy

Published: December 19, 2013

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.

Journal: The Journal of general virology

Published: September 19, 2013

Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.

Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 05, 2013

Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Journal: Antimicrobial agents and chemotherapy

Published: February 06, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026